{"filing":{"accession_number":"0001636422-26-000082","cik":"0001636422","ticker":"HCAT","company_name":"Health Catalyst, Inc.","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"hcat-20260604.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1636422/000163642226000082/hcat-20260604.htm"},"events":[{"id":6981,"run_id":6121,"accession_number":"0001636422-26-000082","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.97,"summary":"Health Catalyst entered into a Unit Purchase Agreement to sell all equity interests of its Vitalware Business to Med-Metrix, LLC for a base purchase price of $147 million, with expected closing in Q3 2026 and proceeds earmarked to repay the company's senior secured term loan facility.","company_name":"Health Catalyst, Inc.","ticker":"HCAT","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":[{"id":4537,"accession_number":"0001636422-26-000082","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Health Catalyst has entered into a Unit Purchase Agreement to sell all equity interests of Vitalware, LLC (the Vitalware Business) to Med-Metrix, LLC for a base purchase price of $147 million. This is a material disposition of a business unit disclosed under Item 1.01 (Entry into a Material Definitive Agreement), with expected closing in Q3 2026 and proceeds earmarked to repay the company's senior secured term loan facility. The transaction is clearly material to investors as it involves the sale of an entire business line and affects the company's capital structure and debt obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:26:20.853862+00:00","company_name":"","ticker":null,"filing_date":""},{"id":4538,"accession_number":"0001636422-26-000082","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses execution of a Purchase Agreement and announcement of a \"Transaction\" involving the sale of Health Catalyst's Vitalware Business to a Buyer, with planned use of proceeds to repay debt. This constitutes a material disposition/sale of a business unit, which is a core M\u0026A activity event. The forward-looking statements reference \"transactions contemplated by the Purchase Agreement\" and an internal reorganization transferring assets and liabilities, confirming the material nature of this transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:26:20.853862+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4537,"accession_number":"0001636422-26-000082","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Health Catalyst has entered into a Unit Purchase Agreement to sell all equity interests of Vitalware, LLC (the Vitalware Business) to Med-Metrix, LLC for a base purchase price of $147 million. This is a material disposition of a business unit disclosed under Item 1.01 (Entry into a Material Definitive Agreement), with expected closing in Q3 2026 and proceeds earmarked to repay the company's senior secured term loan facility. The transaction is clearly material to investors as it involves the sale of an entire business line and affects the company's capital structure and debt obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:26:20.853862+00:00","company_name":"Health Catalyst, Inc.","ticker":"HCAT","filing_date":"2026-06-04"},{"id":4538,"accession_number":"0001636422-26-000082","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses execution of a Purchase Agreement and announcement of a \"Transaction\" involving the sale of Health Catalyst's Vitalware Business to a Buyer, with planned use of proceeds to repay debt. This constitutes a material disposition/sale of a business unit, which is a core M\u0026A activity event. The forward-looking statements reference \"transactions contemplated by the Purchase Agreement\" and an internal reorganization transferring assets and liabilities, confirming the material nature of this transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:26:20.853862+00:00","company_name":"Health Catalyst, Inc.","ticker":"HCAT","filing_date":"2026-06-04"}]}